According to several studies, PKM2 is the predominant isoform in thyroid cancer, and IHC (immunohistochemistry) tests have revealed that tumor cells exhibit significantly higher PKM2 expression than the surrounding normal tissue (Taniguchi et al., 2021), PKM1 is often expressed either low or not at all. Here, PKM is linked to neoplasm.